Capital Impact Advisors’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-44,926
Closed -$80.9K 108
2023
Q3
$80.9K Hold
44,926
0.14% 108
2023
Q2
$310K Hold
44,926
0.34% 135
2023
Q1
$279K Sell
44,926
-1,372
-3% -$9.6K 0.34% 134
2022
Q4
$331K Hold
46,298
0.32% 135
2022
Q3
$352K Buy
46,298
+3,884
+9% +$37.7K 0.35% 121
2022
Q2
$324K Buy
42,414
+23,709
+127% +$167K 0.3% 146
2022
Q1
$144K Buy
18,705
+16,955
+969% +$662K 0.1% 184
2021
Q4
$148K Buy
+1,750
New +$178K 0.1% 96

Other funds holding KOD

Capital Impact Advisors's KOD Position: Q4 2023 in Review

Capital Impact Advisors sold out of Kodiak Sciences (KOD) in Q4 2023, closing a stake of 44,926 shares — an estimated $80.9K sold.

Capital Impact Advisors first reported a position in KOD in Q4 2021 and held it in 8 quarters. The position peaked at $352K in Q3 2022. 96 funds tracked by Wall St. Rank hold KOD as of Q4 2023.

  • Capital Impact Advisors reported no remaining Kodiak Sciences position as of Q4 2023 after selling out during the quarter.
  • Capital Impact Advisors sold 44,926 Kodiak Sciences shares in Q4 2023, an estimated $80.9K.
  • Capital Impact Advisors first reported a position in Kodiak Sciences in Q4 2021 and held it in 8 quarters.
  • Capital Impact Advisors's Kodiak Sciences position peaked at $352K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Kodiak Sciences as of Q4 2023.

Based on Capital Impact Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.